Retargeted delivery of adenoviral vectors through fibroblast growth factor receptors involves unique cellular pathways

FASEB Journal

Volumn 13, Issue 11, 1999, Pages 1459-1466

  Doukas, John ^b   Hoganson, Diana K ^b   Ong, Michael ^b   Ying, Wenbin ^b   Lacey, David L ^a   Baird, Andrew ^b   Pierce, Glenn F ^b   Sosnowski, Barbara A ^b  

^a AMGEN INC   (United States)

^b Selective Genetics Inc   (United States)

Author keywords

Affinity; Cancer; Gene therapy; Integrin

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; PROTEOHEPARAN SULFATE; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; TARGET CELL; TRANSGENE;

EID: 0032782365     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.13.11.1459     Document Type: Article

References (46)

1. Worgall, S., Wolff, G., Falck-Pedersen, E., and Crystal, R. G. (1997) Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum. Gene Ther. 8, 37-44
2. Tomko, R. P., Xu, R., and Philipson, L. (1998) HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl. Acad. Sci. USA 94, 3352-3356
3. Freimuth, P. (1996) A human cell line selected for resistance to adenovirus infection has reduced levels of the virus receptor. J. Virol. 70, 4081-4085
4. Zabner, J., Freimuth, P., Puga, A., Fabrega, A., and Welsh, M. J. (1997) Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection. J. Clin. Invest. 100, 1144-1149
5. Li, Y., Pong, R. C., Bergelson, J. M., Hall, M. C., Sagalowsky, A. I., Tseng, C. P., Wang, Z., and Hsieh, J. T. (1999) Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. Cancer Res. 59, 325-330
6. Wickham, T. J., Carrion, M. E., and Kovesdi, I. (1995) Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Gene Ther. 2, 750-756
7. Douglas, J. T., Rogers, B. E., Rosenfeld, M. E., Michael, S. I., Feng, M., and Curiel, D. T. (1996) Targeted gene delivery by tropism-modified adenoviral vectors. Nat. Biotechnol. 14, 1574-1578
8. Wickham, T. J., Segal, D. M., Roelvink, P. W., Carrion, M. E., Lizonova, A., Lee, G. M., and Kovesdi, I. (1996) Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J. Virol. 70, 6831-6838
9. Wickham, T. J., Roelvink, P. W., Brough, D. E., and Kovesdi, I. (1996) Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types. Nat. Biotechnol. 14, 1570-1573
10. Stevenson, S. C., Rollence, M., Marshall-Neff, J., and McClelland, A. (1997) Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein. J. Virol. 71, 4782-4790
11. Watkins, S. J., Mesyanzhinov, V. V., Kurochkina, L. P., and Hawkins, R. E. (1997) The 'adenobody' approach to viral targeting: specific and enhanced adenoviral gene delivery. Gene Ther. 4, 1004-1012
12. Wickham, T. J., Lee, G. M., Titus, J. A., Sconocchia, G., Bakacs, T., Kovesdi, I., and Segal, D. M. (1997) Targeted adenovirus-mediated gene delivery to T cells via CD3. J. Virol. 71, 7663-7669
13. Wickham, T. J., Haskard, D., Segal, D., and Kovesdi, I. (1997) Targeting endothelium for gene therapy via receptors upregulated during angiogenesis and inflammation. Cancer Immunol. Immunother. 45, 149-151
14. Goldman, C. K., Rogers, B. E., Douglas, J. T., Sosnowski, B. A., Ying, W., Siegal, G. P., Baird, A., Campain, J. A., and Curiel, D. T. (1997) Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor. Cancer Res. 57, 1447-1451
15. Reynolds, P. N., Miller, C. R., Goldman, C. K., Doukas, J., Sosnowski, B. A., Rogers, B. E., Gomez-Navarro, J., Pierce, G. F., Curiel, D. T., and Douglas, J. T. (1998) Targeting adenoviral infection with basic fibroblast growth factor enhances gene delivery to vascular endothelial and smooth muscle cells. Tumor Targeting 3, 156-168
16. Rogers, B. E., Douglas, J. T., Sosnowski, B. A., Ying, W., Pierce, G., Buchsbaum, D. J., Della Manna, D., Baird, A., and Curiel, D. T. (1998) Enhanced in vivo gene delivery to human ovarian cancer xenografts utilizing a tropism-modified adenovirus vector. Tumor Targeting 3, 25-31
17. Rancourt, C., Rogers, B. E., Sosnowski, B. A., Wang, M., Piche, A., Pierce, G. F., Alvarez, R. D., Siegal, G. P., Douglas, J. T., and Curiel, D. T. (1998) Basic fibroblast growth factor enhancement of adenovirus-mediated delivery of the herpes simplex virus thymidine kinase gene results in augmented therapeutic benefit in a murine model of ovarian cancer. Clin. Cancer Res. 4, 2455-2461
18. v integrins. Trends Cell Biol. 4, 52-55
19. 5 promote adenovirus internalization but not virus attachment. Cell 73, 309-319
20. Klagsburn, M., and Baird, A. (1991) A dual receptor system is required for basic fibroblast growth factor activity. Cell 67, 229-231
21. Whalen, G. F., Shing, Y., and Folkman, J. (1989) The fate of intravenously administered bFGF and the effect of heparin. Growth Factors 1, 157-164
22. Lindner, V., and Reidy, M. A. (1993) Expression of basic fibroblast growth factor and its receptor by smooth muscle cells and endothelium in injured rat arteries. An en face study. Circ. Res. 73, 589-595
23. Takanami, I., Tanaka, F., Hashizume, T., and Kodaira, S. (1997) Tumor angiogenesis in pulmonary adenocarcinomas: relationship with basic fibroblast growth factor, its receptor, and survival. Neoplasma 44, 295-298
24. Wang, Y., and Becker, D. (1997) Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth. Nat. Med. 3, 887-893
25. Sosnowski, B. A., Gonzalez, A. M., Chandler, L. A., Buechler, Y. J., Pierce, G. F., and Baird, A. (1996) Targeting DNA to cells with basic fibroblast growth factor (FGF2). J. Biol. Chem. 271, 33647-33653
26. Housley, R. M., Morris, C. F., Boyle, W., Ring, B., Biltz, R., Tarpley, J. E., Aukerman, S. L., Devine, P. L., Whitehead, R. H., and Pierce, G. F. (1994) Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract. J. Clin. Invest. 94, 1764-1777
27. 125-fibroblast growth factor-2 after intracerebral injection. Brain Res. 665, 285-292
28. Doukas, J., Majno, G., and Mordes, J. P. (1996) Anti-endothelial cell autoantibodies in BB rats with spontaneous and induced IDDM. Diabetes 45, 1209-1216
29. Gonzalez, A. M., Logan, A., Ying, W., Lappi, D. A., Berry, M., and Baird, A. (1994) Fibroblast growth factor in the hypothalamic-pituitary axis: differential expression of fibroblast growth factor-2 and a high affinity receptor. Endocrinology 134, 2289-2297
30. Greber, U. F., Willetts, M., Webster, P., and Helenius, A. (1993) Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75, 477-486
31. Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P., and Ornitz, D. M. (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841-848
32. Bottaro, D. P., Rubin, J. S., Ron, D., Finch, P. W., Florio, C., and Aaronson, S. A. (1990) Characterization of the receptor for keratinocyte growth factor. Evidence for multiple fibroblast growth factor receptors. J. Biol. Chem. 265, 12767-12770
33. Ornitz, D. M., Xu, J., Colvin, J. S., McEwen, D. G., MacArthur, C. A., Coulier, F., Gao, G., and Goldfarb, M. (1996) Receptor specificity of the fibroblast growth factor family. J. Biol. Chem. 271, 15292-15297
34. Ying, W., Martineau, D., Kiefer, M., Lappi, D. A., and Baird, A. (1993) Characterization and activities of an anti-basic fibroblast growth factor receptor immunotoxin. Proc. Am. Assoc. Cancer Res. 34, 480 (abstr.)
35. Chandler, L. A., Sosnowski, B. A., Greenlees, L., Aukerman, S. L., Baird, A., and Pierce, G. F. (1999) Prevalent expression of functional fibroblast growth factor (FGF) receptors and FGF2 in human tumor cell lines. Int. J. Cancer 81, 451-458
36. Gu, D., Hoganson, D. K., Printz, M., Gonzalez, A. M., Ying, W., Sosnowski, B. A., Curiel, D. T., Pierce, G. F., and Aukerman, S. L. (1998) Retargeting adenovirus vectors with FGF-2 leads to enhanced efficacy and decreased toxicity. Proc. Am. Assoc. Cancer Res. 39, 512 (abstr.)
37. Rapraeger, A. C. (1995) In the clutches of proteoglycans: how does heparan sulfate regulate FGF binding? Chem. Biol. 2, 645-649
38. Venkataraman, G., Sasisekharan, V., Herr, A. B., Ornitz, D. M., Waksman, G., Cooney, C. L., Langer, R., and Sasisekharan, R. (1996) Preferential self-association of basic fibroblast growth factor is stabilized by heparin during receptor dimerization and activation. Proc. Natl. Acad. Sci. USA 93, 845-850
39. Geppert, T. D., and Lipsky, P. E. (1987) Accessory cell independent proliferation of human T4 cells stimulated by immobilized monoclonal antibodies to CD3. J. Immunol. 138, 1660-1666
40. Herr, A. B., Ornitz, D. M., Sasisekharan, R., Venkataraman, G., and Waksman, G. (1997) Heparin-induced self-association of fibroblast growth factor-2. Evidence for two oligomerization processes. J. Biol. Chem. 272, 16382-16389
41. Givol, D., and Yayon, A. (1992) Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J. 6, 3362-3369
42. Gleizes, P. E., Noaillac-Depeyre, J., Amalric, F., and Gas, N. (1995) Basic fibroblast growth factor (FGF-2) internalization through the heparan sulfate proteoglycans-mediated pathway: an ultrastructural approach. Eur. J. Cell Biol. 66, 47-59
43. Prudovsky, I., Savion, N., Zhan, X., Friesel, R., Xu, J., Hou, J., McKeehan, W. L., and Maciag, T. (1994) Intact and functional fibroblast growth factor (FGF) receptor-1 trafficks near the nucleus in response to FGF-1. J. Biol. Chem. 269, 31720-31724
44. Bachmann, M. F., Kalinke, U., Althage, A., Freer, G., Burkhart, C., Roost, H. P., Aguet, M., Hengartner, H., and Zinkernagel, R. M. (1997) The role of antibody concentration and avidity in antiviral protection. Science 276, 2024-2027
45. Kwok, T. T., and Sutherland, R. M. (1991) Differences in EGF related radiosensitisation of human squamous carcinoma cells with high and low numbers of EGF receptors. Br. J. Cancer 64, 251-254
46. Larocca, D., Witte, A., Johnson, W., Pierce, G. F., and Baird, A. (1998) Targeting bacteriophage to mammalian cell surface receptors for gene delivery. Hum. Gene Ther. 9, 2393-2399